On ECHEMI
Home > Drugs > Kunming Baima Pharmaceutical Co., Ltd.
Kunming Baima Pharmaceutical Co., Ltd.
  • Founded in:

    1995-03-11
  • Country:

    China China
  • Address:

    No. 998, Kegao Road, High-tech Zone, Kunming City, Yunnan Province
  • Tax NO.:

    91530100216614669W
  • Registered Funds:

    10 million yuan
  • Website:

  • Email:

Related Drugs
Thrombin
This product is a sterile lyophilized product of prothrombin extracted from bovine or pig blood and activated to obtain thrombin. The potency of each 1mg should not be less than 10 units. The thrombin content should be more than 80% of the labeled amount.
Name Description Content CAS NO. Registered Holders
Thrombin

It promotes the conversion of fibrinogen into fibrin, which is applied to wounds to coagulate blood and stop bleeding.

More

It promotes the conversion of fibrinogen into fibrin, which is applied to wounds to coagulate blood and stop bleeding.

More than 80% of the labeled amountUnit/mg 9002-04-4 3
Cytochrome C for injection
Name Description Content CAS NO. Registered Holders
Cytochrome C

Not clearly described

More

Not clearly described

9007-43-6 0
RNA for injection
RNA.
Name Description Content CAS NO. Registered Holders
Ribonucleic acid

Hepatitis auxiliary medicine, can improve the body's cellular immune function, promote liver cell protein synthesis, reduce glutamic acid alanine aminotransferase

More

Hepatitis auxiliary medicine, can improve the body's cellular immune function, promote liver cell protein synthesis, reduce glutamic acid alanine aminotransferase

63231-63-0 0
Mannan peptide injection
Name Description Content CAS NO. Registered Holders
Mannatide

613263-58-4 5
Thrombin
This product is a sterile lyophilized product of prothrombin extracted from bovine or pig blood and activated to obtain thrombin. The potency of each 1mg should not be less than 10 units. The thrombin content should be more than 80% of the labeled amount.
Name Description Content CAS NO. Registered Holders
Thrombin

It promotes the conversion of fibrinogen into fibrin, which is applied to wounds to coagulate blood and stop bleeding.

More

It promotes the conversion of fibrinogen into fibrin, which is applied to wounds to coagulate blood and stop bleeding.

More than 80% of the labeled amountUnit/mg 9002-04-4 3
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.